60.72 USD
▲+0.11+1.20%
2026-08-03
市值
$11.74B
市盈率
43.48
EPS
1.40
股息率
—
52 周区间
49.26 – 66.28
成交量
1.24M
Beta
0.24
目标价
87.92
52W 低 49.2652W 高 66.28
价格走势
公司简介
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NA...